NASH in Subjects With Different Classes of Obesity
NCT04653103 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2021-05-18
Summary
It is an observational trial on 500 subjects. The purpose of this trial is to assess the prevalence of non-alcoholic steatohepatitis (NASH) in subjects with different classes of obesity.
Conditions
- NASH - Nonalcoholic Steatohepatitis
- NAFLD
- Obesity
- Obesity, Morbid
Interventions
- PROCEDURE
-
Liver biopsy
Biopsy of the liver to assess for Non-alcoholic steatohepatitis
Sponsors & Collaborators
-
Catholic University of the Sacred Heart
lead OTHER
Principal Investigators
-
Geltrude Mingrone, MD, PhD · Catholic University of the Sacred Heart
Eligibility
- Min Age
- 19 Years
- Max Age
- 69 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-11-20
- Primary Completion
- 2021-01-25
- Completion
- 2023-01-25
Countries
- Italy
Study Locations
More Related Trials
-
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
NCT04054310 ·Status: RECRUITING ·Phase: NA
-
DIAbetes and NAFLD
NCT06315361 ·Status: ACTIVE_NOT_RECRUITING
-
Fibrosis Reduction in Non Alcoholic Steatohepatitis
NCT05798702 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Longitudinal Observational Study Of Chinese With NAFLD/NASH
NCT03151473 ·Status: RECRUITING
-
Identification of Protective and Worsening Steatohepatitis (NASH) Factors
NCT00914446 ·Status: UNKNOWN ·Phase: NA
-
Non Invasive Measurements of Fibrosis, Inflammation and Steatohepatitis in Morbidly Obese Patients
NCT01695083 ·Status: COMPLETED
-
Study Visceral Adipose Tissue and Liver Stifness in a Retrospective Cohort of Diabetes Mellitus Patients
NCT04493814 ·Status: UNKNOWN
-
Prospective Cohort Study in Patients With NAFLD
NCT00575133 ·Status: RECRUITING
-
NASH and Coronary Disease
NCT03819283 ·Status: UNKNOWN ·Phase: NA
-
Accuracy of Imaging Techniques in Diagnosing Steatohepatitis and Fibrosis in NAFLD Patients
NCT04785937 ·Status: RECRUITING ·Phase: NA
-
Point-of-care Ultrasound Screening and Assessment of Chronic Liver Diseases and NASH
NCT05120557 ·Status: UNKNOWN ·Phase: NA
-
Biomarkers in the Diagnosis and Prognosis of NAFLD
NCT06098417 ·Status: RECRUITING
-
Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) Utilizing Ultrasound and Percutaneous Liver Biopsy
NCT01100398 ·Status: COMPLETED
-
Dynamic Changes and Risk Factors of Fibrosis and Steatosis Progression in Nonalcoholic Fatty Liver Disease
NCT03635541 ·Status: UNKNOWN
-
Evaluation of Risk of hEpatocellular Carcinoma
NCT06523179 ·Status: RECRUITING ·Phase: NA
-
Screening of Liver Fibrosis Using Blood Tests in Patients With Type 2 Diabetes Mellitus
NCT04232293 ·Status: COMPLETED ·Phase: NA
-
Biomarkers of Steatohepatitis in Type 2 Diabetes Patients
NCT07098520 ·Status: NOT_YET_RECRUITING
-
Assessment of Nonalcoholic Fatty Liver Disease in Diabetic and Prediabetic Patients Using Noninvasive Methods.
NCT04553796 ·Status: UNKNOWN
-
Optimizing Noninvasive assessMent Of DysmEtabolic Compensated Advanced Liver Disease
NCT06888310 ·Status: RECRUITING ·Phase: NA
-
NASH: Non-invasive Diagnostic Markers and Imaging
NCT02717000 ·Status: UNKNOWN
-
Head-to-Head Comparison of Hepatocellular Cancer (HCC) Screening Strategies: A Prospective Population-Based Cohort Study in Zhongshan City
NCT07010198 ·Status: RECRUITING
-
Non-invasive Evaluation of Liver Fibrosis, Steatosis, and NASH in NAFLD
NCT03725631 ·Status: UNKNOWN ·Phase: NA
-
Fatty Liver and Ectopic Fat in Overweight and Obese Patients
NCT00886301 ·Status: COMPLETED ·Phase: NA
-
Omics Techniques in Fatty Liver Disease
NCT05907408 ·Status: UNKNOWN
-
Prospective Cohort, With Biobanking, of Patients With Nonalcoholic Fatty Liver Disease
NCT02422238 ·Status: RECRUITING